---
title: "Qingdao Haier Biomedical Co., Ltd. (688139.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688139.SH.md"
symbol: "688139.SH"
name: "Qingdao Haier Biomedical Co., Ltd."
industry: "Health Care Equipment"
datetime: "2026-05-20T22:47:19.282Z"
locales:
  - [en](https://longbridge.com/en/quote/688139.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688139.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688139.SH.md)
---

# Qingdao Haier Biomedical Co., Ltd. (688139.SH)

## Company Overview

Qingdao Haier Biomedical Co.,Ltd engages in the research and development, manufacture, marketing, and sale of low temperature storage equipment for biomedical samples in China and internationally. The company offers ULT freezers, pharmacy refrigerators, freezers, automatic storage solutions, cryogenics, active temperature controlled RKN containers, and RTMD products; and CO2 incubation, standard incubators, biological safety cabinets, clean benches and laminar, and sterilization products. It also provides floor standing, benchtop refrigerated, and benchtop centrifuges; intelligent pharmacy automation and RFID pharmacy products; blood bank refrigerators, blood component management products, blood plasma freezers, and transport coolers; and vaccine storage, cold/freezer room, medical waste disposal equipment, and other products. In addition, the company offers freezer and controlled rate freezers; microwave digestion system; UV visible spectrophotometer and total organic carbon analyzer products; and consumables.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | CN Market |
| Website | [www.haierbiomedical.com](https://www.haierbiomedical.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:09.000Z

**Overall: C (0.45)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 38 / 64 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 0.26% |  |
| Net Profit YoY | -35.18% |  |
| P/B Ratio | 2.38 |  |
| Dividend Ratio | 1.39% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 10615030517.74 |  |
| Revenue | 2295837937.94 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 4.94% | C |
| Profit Margin | 9.60% | B |
| Gross Margin | 47.55% | B |
| Revenue YoY | 0.26% | C |
| Net Profit YoY | -35.18% | D |
| Total Assets YoY | 0.43% | C |
| Net Assets YoY | -0.14% | D |
| Cash Flow Margin | 110.19% | C |
| OCF YoY | 0.26% | C |
| Turnover | 0.39 | C |
| Gearing Ratio | 19.70% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Qingdao Haier Biomedical Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "0.26%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-35.18%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.38",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "1.39%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "10615030517.74",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "2295837937.94",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "4.94%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "9.60%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "47.55%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "0.26%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-35.18%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "0.43%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "-0.14%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "110.19%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "0.26%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.39",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "19.70%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 47.85 | 27/64 | 41.57 | 39.09 | 31.28 |
| PB | 2.36 | 21/64 | 2.49 | 2.40 | 2.28 |
| PS (TTM) | 4.59 | 18/64 | 4.70 | 4.56 | 4.34 |
| Dividend Yield | 1.40% | 20/64 | 1.49% | 1.43% | 1.38% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | APT (688617.SH) | A | B | B | A | B | A |
| 02 | United Imaging Healthcare (688271.SH) | B | A | C | B | B | B |
| 03 | iRay (688301.SH) | B | A | D | C | A | B |
| 04 | YUYUE MEDICAL (002223.SZ) | B | C | C | A | C | B |
| 05 | Insight Lifetech (688712.SH) | B | A | E | A | A | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-11T16:00:00.000Z

Total Analysts: **3**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 2 | 67% |
| Overweight | 1 | 33% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 33.25 |
| Highest Target | 35.00 |
| Lowest Target | 35.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/688139.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/688139.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/688139.SH/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/688139.SH/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**